Beijing Bohui Innovation Technology Co Ltd (300318) - Total Assets

Latest as of September 2025: CN¥4.33 Billion CNY ≈ $632.97 Million USD

Based on the latest financial reports, Beijing Bohui Innovation Technology Co Ltd (300318) holds total assets worth CN¥4.33 Billion CNY (≈ $632.97 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 300318 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Beijing Bohui Innovation Technology Co Ltd - Total Assets Trend (2004–2024)

This chart illustrates how Beijing Bohui Innovation Technology Co Ltd's total assets have evolved over time, based on quarterly financial data. Explore 300318 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Beijing Bohui Innovation Technology Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Beijing Bohui Innovation Technology Co Ltd's total assets of CN¥4.33 Billion consist of 29.7% current assets and 70.3% non-current assets.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 1.9%
Accounts Receivable CN¥113.01 Million 2.7%
Inventory CN¥1.01 Billion 24.5%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥411.63 Million 10.0%
Goodwill CN¥786.27 Million 19.1%

Asset Composition Trend (2004–2024)

This chart illustrates how Beijing Bohui Innovation Technology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Beijing Bohui Innovation Technology Co L market cap and net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Beijing Bohui Innovation Technology Co Ltd's current assets represent 29.7% of total assets in 2024, a decrease from 97.7% in 2004.
  • Cash Position: Cash and equivalents constituted 1.9% of total assets in 2024, down from 59.3% in 2004.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 28.0% of total assets, an increase from 0.0% in 2004.
  • Asset Diversification: The largest asset category is inventory at 24.5% of total assets.

Beijing Bohui Innovation Technology Co Ltd Competitors by Total Assets

Key competitors of Beijing Bohui Innovation Technology Co Ltd based on total assets are shown below.

Company Country Total Assets
Ascendis Pharma AS
NASDAQ:ASND
USA $2.01 Billion
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
USA $8.59 Billion
Spyre Therapeutics Inc.
NASDAQ:SYRE
USA $763.95 Million
3SBio Inc
F:83B
Germany €36.25 Billion
Soleno Therapeutics Inc
NASDAQ:SLNO
USA $608.39 Million
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497
China CN¥4.48 Billion
Novavax Inc
NASDAQ:NVAX
USA $1.04 Billion
BB Biotech AG
SW:BION
Switzerland CHF2.64 Billion

Beijing Bohui Innovation Technology Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.03 1.26 0.54
Quick Ratio 0.22 0.28 0.15
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥38.71 Million CN¥259.98 Million CN¥-913.91 Million

Beijing Bohui Innovation Technology Co Ltd - Advanced Valuation Insights

This section examines the relationship between Beijing Bohui Innovation Technology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 3.79
Latest Market Cap to Assets Ratio 0.13
Asset Growth Rate (YoY) 5.1%
Total Assets CN¥4.13 Billion
Market Capitalization $531.95 Million USD

Valuation Analysis

Below Book Valuation: The market values Beijing Bohui Innovation Technology Co Ltd's assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Beijing Bohui Innovation Technology Co Ltd's assets grew by 5.1% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Beijing Bohui Innovation Technology Co Ltd (2004–2024)

The table below shows the annual total assets of Beijing Bohui Innovation Technology Co Ltd from 2004 to 2024.

Year Total Assets Change
2024-12-31 CN¥4.13 Billion
≈ $603.70 Million
+5.08%
2023-12-31 CN¥3.93 Billion
≈ $574.50 Million
+0.46%
2022-12-31 CN¥3.91 Billion
≈ $571.86 Million
+5.91%
2021-12-31 CN¥3.69 Billion
≈ $539.97 Million
-0.68%
2020-12-31 CN¥3.72 Billion
≈ $543.66 Million
+37.88%
2019-12-31 CN¥2.69 Billion
≈ $394.31 Million
-0.65%
2018-12-31 CN¥2.71 Billion
≈ $396.90 Million
-0.92%
2017-12-31 CN¥2.74 Billion
≈ $400.58 Million
+30.71%
2016-12-31 CN¥2.09 Billion
≈ $306.46 Million
+1.16%
2015-12-31 CN¥2.07 Billion
≈ $302.93 Million
+158.99%
2014-12-31 CN¥799.34 Million
≈ $116.97 Million
+6.24%
2013-12-31 CN¥752.40 Million
≈ $110.10 Million
+7.30%
2012-12-31 CN¥701.23 Million
≈ $102.61 Million
+167.95%
2011-12-31 CN¥261.70 Million
≈ $38.29 Million
+21.90%
2010-12-31 CN¥214.68 Million
≈ $31.41 Million
+20.68%
2009-12-31 CN¥177.90 Million
≈ $26.03 Million
+22.35%
2008-12-31 CN¥145.40 Million
≈ $21.28 Million
+37.17%
2007-12-31 CN¥106.00 Million
≈ $15.51 Million
+31.62%
2006-12-31 CN¥80.53 Million
≈ $11.78 Million
+5.79%
2005-12-31 CN¥76.12 Million
≈ $11.14 Million
+31.94%
2004-12-31 CN¥57.70 Million
≈ $8.44 Million
--

About Beijing Bohui Innovation Technology Co Ltd

SHE:300318 China Biotechnology
Market Cap
$531.95 Million
CN¥3.64 Billion CNY
Market Cap Rank
#12054 Global
#3501 in China
Share Price
CN¥4.45
Change (1 day)
-1.11%
52-Week Range
CN¥4.45 - CN¥8.17
All Time High
CN¥21.16
About

Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; albumin; human prothrombin complex; and vaccine for rabies. It also provides molecular platform, such as Automatic Real-time Fl… Read more